upper quadrants, we prefer to remove it through a suprapubic incision.
excision.
AVith regard to Dr. Valentine's proper criticism, in an abbrev¬ iated paper one can hardly do the subject of stricture justice.
He has assumed that I did not say that some strictures are so tight as to require the retention of a filiform bougie for two or three days, whereas the limit I stated, namely 7 French, applied only to the initial application of tunneled sounds in a closed stricture. A 15 French sound is a little too small for the average case unless a guide is also used. Dr. Valentine stated that the acme of cure is the restoration of the mucosa to its normal condition. I do not believe that that is pos¬ sible in the preponderating majority of cases of stricture because strictures proceed from destroyed mucous membrane which cannot be restored. Stricture is sometimes periurethral scar tissue which cannot be removed but only dilated or stretched so as to obviate the obstruction. The cutting opera¬ tion must be followed up by the passage of sounds and only recently I saw a case in point that had been operated on a number of times ineifectually simply because no Among those drugs which act as direct stimulants to the heart's action none have been found which are able to replace fhe preparations of Digitalis purpurea. It has long been clearly recognized, however, that digitalis medi¬ cation is complicated by a number of undesirable second¬ ary effects. Briefly, these are its accumulative action, its tendency to produce disorders of appetite and diges¬ tion, and, finally, its irritant action, which interferes with its use by the hypodermic method. These untoward effects are so marked at times as to prevent the use of the drug; they always make great caution necessary in the administration in order that dangerous toxic effects may not follow.
The use of digitalis is further complicated by the fact that its therapeutic effects often do not appear until about the second day after medication is started, a draw¬ back which makes it of practically no value in cases of acute heart failure. In certain cases the effect fails to appear even after several days, while in others the first indication that the drug has been absorbed is the appear¬ ance of symptoms of poisoning. These latter disagree¬ able features of the drug's action are usually ascribed to differences in the reaction of the patient, but it seems equally or even more probable that-they are often due to variations in the potency of the drug used, the prepara¬ tion being in one ease much weaker, in another much more active than the normal.
Many attempts have been made from time to time to secure a digitalis preparation without these various unde¬ sirable qualities. Unfortunately, however, these efforts have not resulted in much success, although a large num¬ ber of special formulas have been used in preparing the crude drug for therapeutic use. In this connection, the so-called pure principles of digitalis have been suggested as offering a solution of the problem. These, however, although possessing the desirable effects of the crude drug are by no means free from its undesirable secondary effects. Of these digitoxin, the glucosid which occurs in the greatest amount in digitalis leaves, is by far the most potent. The use of digitoxin in therapeutics is made practically impossible, however, by its excessively irritant action, its tendency to produce disorders of digestion, its marked accumulative action, and, less important, its insolubility in water, which makes its administration difficult excepting in tablet form. In 1904, however, Cloetta1 announced that as a result of several years' labor he had been able to isolate a digitoxin from digi¬ talis leaves which was almost entirely devoid of these drawbacks» This new digitoxin (for sale under the trade name digalen) from a physical standpoint dif¬ fered from the crystalline product of Schmiedeburg and Kiliani in being amorphous and in being much more soluble in water. From the therapeutic stand¬ point, according to Cloetta, it differed even more widely, being easily absorbed, the digitalis effect appear¬ ing within twenty-four hours, being without accumula¬ tive or toxic action and being so free from irritant quali¬ ties as to make it suitable for subcutaneous, intramuscu¬ lar or intravenous injection. Moreover, being a definite chemical substance, it afforded a preparation entirely devoid of the variability so often present in the crude drug.
Aside from Cloetta's own investigation, the only work done regarding the identity of digalen with crystalline digitoxin was carried out by Kiliani,2 who has done far more work on the chemistry of digitalis than any other investigator. He was unable to accept Cloetta's view, but rather pointed out that the formula given by Cloetta3 for digalen does not correspond to that for the crystal¬ line substance, the former having a formula of C14H230with a molecular weight of 287, the latter of C34H54011, a molecular weight of 638. Kiliani concludes that diga¬ len is only a high percentage of digitalein.
Clinical results would seem to indicate that Cloetta and a number of the clinicians who reported invariably good effects from digalen were in error (or based their conclusions on an inadequate number of cases) regard¬ ing the superiority of amorphous digitoxin over the older preparations of digitalis. A review of the literature (Beitter,* Vlach,5 Frankel,6 Mueller7) shows that diga¬ len is not devoid of cumulative action; that it possesses marked irritating properties, so irritant as to make sub¬ cutaneous injection practically impossible, causing edema and pain, lasting in some cases for two and three days and often causing great pain when given intramuscu¬ larly, or if given intravenously causing in some cases edema and thrombosis . (Kottmann,8 Hochheim,9 Liverato,10 Veiel,11 Teichmann12) ; that it causes disturbances of digestion apparently as often as the older galenicals, with loss of appetite, nausea and vomiting (Eichhorst,13 Veiel,11 Teichman,12 Mueller7), and that its effects do not appear more rapidly than from corresponding doses (based on the manufacturer's claim that 0.3 mg. amor¬ phous digitoxin (Cloetta) = 0.150 gm. folia digitalis) of the older preparation. Mueller,7 in a series of 18 cases, observed effects from doses of 6 c.c. of digalen on the second day, namely, increased amounts of urine or a decrease in heart rate. From doses of 5 c.c. the effect appeared first on the second and third day, doses of from 3 to 4 c.c. on the third to the fifth day, and from doses of 2.25 c.c. the action appeared on the fourth to the fifth day. From doses of 400 mg. of folia digitalis (in terms of digalen 2.66 c.c.) the effect appeared on the second day ; 300 mg. of the leaves (equal to 2 c.c. diga¬ len) produced effects on the third day, and Mueller remarks that these effects were not only more constant, but were also more powerful than from digalen. To facilitate comparison, these results are summarized in the following table. Eegarding the claim that digalen is an efficient remedy in acute heart failure, von Ketly" reported that the effects did not appear more quickly when given subcutaneously than by the mouth. Kottmann8 reported, how¬ ever, that if digalen was given intravenously in large doses, 5 to 15 c.c. (amounts which were necessary to produce a distinct digitalis action) the action appeared in from two to five minutes. The danger of this method of exhibition makes such a use very questionable, how¬ ever, as Teichmann12 observed edema and thrombosis and, in one case, after a dose of 4 c.c, general tonicclonic convulsions.
It seems rather strange that digalen has been accorded so much attention at the hands of the clinician in view of these reports and that so few experiments have been car¬ ried out on animals. A few investigations have been carried out, however, and these have tended to show that digalen had a true digitalis action-a result entirely in accord with Kiliani's report, however, that digalen was only an impure digitalein-the latter glucosid also hav¬ ing the same effect as digitoxin on the heart, excepting that it is manifested to a lesser degree. It seems doublystrange on account of Kiliani's denial of the chemical identity of this new digitoxin with the older crystalline substance that comparative studies were not made along the lines used in the biologic standardization of the digi¬ talis series. Neave,10 apparently the only investigator to make such a study, reported from The most accurate method of determining the thera¬ peutic value of digitalis preparations is biologic rather than chemical. Of the various biologic methods, that of using the typical action of digitalis on the frog's heart as a final reaction is more commonly used than all other methods, but determinations of the rise in blood-pres¬ sure of the minimum lethal dose for mammals have also been used as tests for the activity of the preparations under question. The method adopted at this laboratory for general use is a frog-heart method. The frogs, Rana pipiáis, are carefully weighed and the dose estimated in terms of grams of body weight of the animal. The drug is injected into the anterior lymph-sac and at the end of an hour the animal is pithed, the heart is exposed and its condition noted. The heart should have just stopped beating and should be in firm systolic contraction. If the dose has been too small to bring this about, larger amounts are given until the desired results are obtained ; if too large, the dose is reduced. Five different samples of digalen20 were examined according to this method.
These were all obtained in the open market, but one had been in stock at this laboratory for about two years and two others for about three years; the remaining two (Samples 4 and 5) were obtained during the summer. The appearance of the various samples was very much the same, although the older preparations appeared some¬ what more tinged with yellow. One sample, however, that of 1905, had evidently undergone some marked chemical change since it contained a considerable amount of a dark brown granular substance,21 a precipitate not present in any of the other samples. These various samples were tested for their effect on the frog's heart in the manner described above and gave the results shown in Table 2 .
From the summary it will be noted that the several samples of digalen varied in value from about 0.02 to over 0.04, the older preparations generally testing weaker than those of more recent manufacture, thus indicating deterioration with age, despite the claim that digalen is a stable preparation of digitalis. In order to compare the value of these samples of digalen with digitoxin and digitalein, experiments were carried out on frogs, using the same experimental proce¬ dure as nearly as possible. The results, using Merck's crystalline digitoxin and Merck's digitalein, are as shown in Table 3 . 20. Through the courtesy of the manufacturers the dates of manufacture for the several samples were obtained, viz., No. 1, 1905; No. 2, 1906 the statement that when the precipitate first formed it was nearly white and that it had become dark on standing. It is also to be noted that in no instance had these samples been opened, so that this change came about as a result of natural causes and was not a deterioration due to opening the bottle, etc. The results of these experiments on frogs would indi¬ cate that digalen, basing conclusions on the assay of the best testing samples, occupied a place between crystalline digitoxin and digitalein, the comparative values, accord¬ ing to the above tests, being crystalline digitoxin 0.008, digalen 0.022, and digitalein 0.028.
Experiments were also carried out to determine the comparative effects of the various samples of digalen on blood-pressure. For this purpose, cats of about the same weight (3,000 to 3,600 grams) were used and were anes¬ thetized for the experiments by ethyl carbamate (urethane) and chloral given by the stomach. The blood-pressures were taken from the carotid artery and the injections of the drug made through the external jugular. In working with digitalis it is ordinarily advis¬ able, on account of its accumulative action, to take no reading except the first as determinative, but in this series, after an interval of an hour, further injections were made and the readings incorporated to make up the average. In all cases 2 c.c. doses were used, and the rise in blood-pressure and the decrease in heart-rate estimated in per cent. The results of this series of experiments are given in Table 4 . The results tabulated in this summary agree in a gen¬ eral way with those obtained in the experiments on the frog's heart, viz. : the oldest preparations give the small¬ est increase in pressure. Exceptions are to be noted, however, in the case of Sample 1, which gives a rela¬ tively marked increase in blood-pressure, but failed to stop the frog's heart in systole. Also Sample 2, which assayed on the frog's heart somewhat higher than Sample 3, has somewhat the lesser effect on the blood-pressure. Blood-pressure experiments were also carried out with digitoxin (Merck) and digitalein (Merck) in order to compare their effect with that obtained from the use of digalen.
The digitoxin was dissolved in 25 per cent, alcohol, the digitalein in 25 per cent, glycerin and 7 per cent, alcohol, the solvents used in the manufacture of digalen.
Digitoxin in three experiments, using 0.2 mg. doses in two cases and 0.4 mg. in the other, gave an average rise in pressure of 22.1 per cent., along with a decrease in rate of 7 per cent.
Digitalein, in an average dose of 1 mg., gave a rise in blood-pressure of 9 per cent. ; the heart-rate was slowed on the average 10 per cent.
In view of the fact that the average rise in bloodpressure from 2 c.c. doses of digalen (0.6 mg. amorphous digitoxin) was only 6.7 per cent., and that the average decrease in rate from the same dose was only 5.6 per cent,, one may conclude that digalen is considerably less active than crystalline digitoxin and that it is of about the same potency as corresponding amounts of digitalein. This conclusion is also borne out by the following series of experiments. White mice of the same lot were weighed, placed in separate jars and injected-beneath the loose skin of the back with digalen, digitoxin (Merck) and digitalein (Merck). The doses were calculated in terms of grams of body weight. Increasing amounts were injected until the minimum lethal dose was obtained. The results of these experiments are given in Table 5 . 
From this table it is apparent that the minimum lethal dose for digalen again is considerably larger than that for digitoxin (for mice about four times). Digitalein, as in other methods of testing, assayed weaker than digalen, but, according to this method, appeared to be very little weaker comparatively.
With regard to the general action of digalen on both frogs and mammals, it appears to possess considerably more stimulant action on the central nervous system than other digitalis preparations. In almost every case in the frog experiments the early symptoms of absorp¬ tion were convulsive movements. At times these were clonic, but more often were tonic in character, the legs being extended and remaining in hyperextension for some time. The effect of digalen on mice was much the same, except that the convulsions were usually clonic in character. In the blood-pressure experiments no convul¬ sions were so clearly present, the animal being anesthe¬ tized, but it was noted that struggling was often a sequel of the injection of even small amounts of digalen and that, to prevent this, further small doses of ethyl carbamate were necessary. It is of interest, in this connec¬ tion, to remember that Teichmann12 reported such symptoms of excessive central nervous system stimula¬ tion in a patient who wras given 4 c.c. digalen intra¬ venously.
CONCLUSIONS
Digalen is not a uniformly stable preparation, as is shown by the gross appearance of Sample 1 and by bio¬ logic tests of the five different samples. Biologic tests also indicate that digalen is relatively much less potent than corresponding amounts of crystalline digitoxin, but that it is of about the same activity as digitalein.
The experience of clinicians indicates that digalen is much less effective than is claimed and that the second¬ ary action of the digitalis group appears equally often after its use as with the older and cheaper galenicals. Its use in cases of acute heart failure, whether by intra¬ muscular or intravenous injection, seems to open serious objection (on account of the pain and danger of throm¬ bosis) and it would apparently be better practice in such cases to use either strophanthin given intramuscularly or one of the preparations of the suprarenal glands by intravenous injection. October, 1909, xxxix, 311,) in a series of diet¬ ing and fasting experiments on human individuals. The amount of creatili appearing in the urine was taken as an indication of the condition of the protein metabolism in that individual, since it was shown, by Benedict as well as by Cath¬ cart himself, that creatin was a constant excretory product during inanition and hence purely of endogenous origin. As soon as food is supplied the creatin practically disappears from the urine. The hypothesis is put forward that the car¬ bohydrates are absolutely essential for endocellular synthetic processes in connection with protein metabolism; that a resynthesis takes place in the tissues (muscles) and that the greater part of the muscle protein tissue nitrogen which is set free as the result of work does not appear in the urine but is reutilized; "further, that the foodstuff which plays the most important rôle in this resynthesis is carbohydrate. Fats apparently must undergo some change which requires time to produce." It is also found that with a carbohydrate diet, practically nitrogen-and fat-free, there is a fall in the ouput of urinary nitrogen; with a fat diet, practically nitrogenand carbohydrate-free, there is a marked rise in the output of urinary nitrogen. This condition of dermamyiasis is apparently rare; I can find but one good description, Hamburger's article in the Journal of Cutaneous Diseases, 1904. Since study¬ ing the two cases here reported, two others have been sent to me, so the apparent rarity of the condition may be due chiefly to its passing unrecognized.
It would seem very much more satisfactory if we could find the larvas of this parasite, but everybody in this country seems to have failed to do so, though sev¬ eral Russian investigators state they have done so. Case 1.-The patient, Mrs. B., first had an attack of the eruption on the right ankle in September, 1908. This lasted two months. The patient went to a hospital, but did not understand what the disease was and apparently went away Creeping eruption on plantar surfaces of feet, Case 2. without any treatment. I did not see this, but according to the patient's description there was a very small elevated pim¬ ple like a mosquito bite, which itched badly, and from this a little red line extended and healing at back end as fast as it extended. The patient could distinctly feel and see the para¬ site's progress; it ran up and down the ankle four or five inches, came back again, then across. Some days it did not move and others it progressed an inch or two inches.
The second attack was about three months after the first.
The eruption made its appearance on the dorsal surface of the left hand. I saw and followed the attack; it was character¬ istic in every respect according to the description in Ham¬ burger's article. A raised red line 2 mm. in diameter and covered at varying intervals with small vesicles commenced in the middle of the back of hand and traveled around the back of the hand in loops, back and forth, and finally ended down between the forefinger and thumb and then apparently died. I failed to demonstrate any larvae. The patient is now well. I treated the second attack with various caustics, antiseptics and by incisions, but cannot say that the treatment had any
